ProKidney Newsroom

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Moomoo NewsNov 13 08:31 ET

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Moomoo NewsNov 13 05:41 ET

ProKidney Analyst Ratings

BenzingaSep 30 09:31 ET

J.P. Morgan Initiates ProKidney(PROK.US) With Hold Rating

Moomoo NewsSep 30 05:31 ET

ProKidney Initiated at Buy by Guggenheim

Dow JonesSep 10 05:58 ET

Guggenheim Initiates ProKidney(PROK.US) With Buy Rating, Announces Target Price $6

Moomoo NewsSep 10 05:31 ET

Buy Rating on ProKidney: Promising Prospects in Chronic Kidney Disease Treatment

TipRanksSep 10 04:48 ET

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Moomoo NewsSep 6 06:33 ET

BofA Securities Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Moomoo NewsSep 4 09:32 ET

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Moomoo NewsSep 4 09:32 ET

ProKidney Is Maintained at Neutral by B of A Securities

Dow JonesSep 4 08:19 ET

ProKidney Analyst Ratings

BenzingaSep 4 08:08 ET

BofA Securities Maintains ProKidney(PROK.US) With Hold Rating, Cuts Target Price to $3

Moomoo NewsSep 4 06:31 ET

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Moomoo NewsSep 4 06:31 ET

Maintaining Hold on ProKidney Amid Strategic Shifts and Regulatory Uncertainties

TipRanksSep 4 06:09 ET

ProKidney's Hold Rating Maintained Amid Financing and Clinical Uncertainties

TipRanksSep 4 05:50 ET

BTIG Maintains ProKidney(PROK.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsSep 4 04:31 ET

ProKidney Analyst Ratings

BenzingaJun 10 14:18 ET

ProKidney Analyst Ratings

BenzingaMay 29 05:22 ET

B of A Securities Maintains Neutral on ProKidney, Raises Price Target to $4

BenzingaMay 29 05:21 ET